Xufu Wei
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Circular RNAs in diseases 4
- RNA modifications and cancer 4
- Ubiquitin and proteasome pathways 2
- Epigenetics and DNA Methylation 2
-
- MicroRNA in disease regulation 8
- Cancer-related molecular mechanisms research 7
- Co-authors
- Zhongjun Wu (24 shared papers)Chengyong Tang (10 shared papers)Rui Liu (6 shared papers)Daofeng Zheng (8 shared papers)Guosheng Ren (2 shared papers)Cui Tan (2 shared papers)Tingxiu Xiang (2 shared papers)Junliang Pu (7 shared papers)
- Journals
- Frontiers in Oncology (3 papers)Cellular Signalling (3 papers)Oncotarget (2 papers)Hepatology (1 paper)Cell Reports (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xufu Wei
33 papers receiving 902 citations
Peers
Comparison fields: 5 of 70
- Cancer Research 349
- Hepatology 113
- Immunology 155
- Molecular Biology 467
- Epidemiology 175
Countries citing papers authored by Xufu Wei
This map shows the geographic impact of Xufu Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xufu Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xufu Wei more than expected).
Fields of papers citing papers by Xufu Wei
This network shows the impact of papers produced by Xufu Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xufu Wei. The network helps show where Xufu Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Xufu Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 129 | |
| 2 | 2013 | 94 | |
| 3 | 2017 | 81 | |
| 4 | 2015 | 70 | |
| 5 | 2013 | 47 | |
| 6 | 2018 | 46 | |
| 7 | 2016 | 43 | |
| 8 | 2016 | 42 | |
| 9 | 2017 | 42 | |
| 10 | 2021 | 37 | |
| 11 | 2016 | 34 | |
| 12 | 2017 | 30 | |
| 13 | 2013 | 22 | |
| 14 | 2021 | 20 | |
| 15 | 2021 | 18 | |
| 16 | 2015 | 17 | |
| 17 | 2020 | 15 | |
| 18 | 2017 | 15 | |
| 19 | 2022 | 12 | |
| 20 | 2021 | 12 |
About Xufu Wei
Xufu Wei is a scholar working on Molecular Biology, Cancer Research, Oncology, Epidemiology and Surgery, having authored 35 papers that have together received 908 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (7 papers), Circular RNAs in diseases (4 papers), Autophagy in Disease and Therapy (4 papers), RNA modifications and cancer (4 papers), Sirtuins and Resveratrol in Medicine (3 papers), Ubiquitin and proteasome pathways (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Cancer Research (349 citations), Hepatology (113 citations), Immunology (155 citations), Molecular Biology (467 citations) and Epidemiology (175 citations). Xufu Wei has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Zhongjun Wu, Chengyong Tang, Rui Liu, Daofeng Zheng, Guosheng Ren, Cui Tan, Tingxiu Xiang, Junliang Pu, Tong Mou and Zhen Guo. Their work appears in journals such as Frontiers in Oncology, Cellular Signalling, Oncotarget, Hepatology and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.